Ventris Medical receives FDA 510(k) clearance for synthetic bone graft putty
Click Here to Manage Email Alerts
Key takeaways:
- Ventris Medical received FDA 510(k) clearance of its Amplify synthetic bone graft putty for the intervertebral disc space.
- The putty can be used as a standalone product or in combination with autograft bone.
Ventris Medical received FDA 510(k) clearance of its Amplify standalone bone graft putty, according to a company press release.
Amplify is designed to aid cell proliferation and bone formation in the intervertebral disc space. According to the release, the putty can be used as a standalone product or as a bone graft extender in combination with autograft bone.
“We are pleased to receive FDA clearance for Amplify synthetic bone graft putty for the intervertebral disc space,” Russell Cook, CEO of Ventris Medical, said in the release. “This technology combines two heavily studied biphasic mineral components, which are surface activated through our patented process and suspended in our proprietary polymer carrier. In a market crowded with a plethora of commodity offerings, our company mission is to develop next generational devices that bring excitement to the surgeon community as well as our distribution partners.”
Read more about
Click Here to Manage Email Alerts